VEGFA and retinopathy of prematurity: Key management strategies include timely laser photocoagulation for treatment-requiring ROP, where feasible, and intravitreal anti-vascular endothelial growth factor (VEGF) therapy as a preferred or initial option in posterior disease and aggressive ROP (A-ROP), with prolonged surveillance for reactivation.